Federation des caisses Desjardins du Quebec’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,207
Closed -$772K 2652
2021
Q2
$772K Sell
4,207
-3,120
-43% -$573K 0.01% 771
2021
Q1
$1.12M Sell
7,327
-100,336
-93% -$15.3M 0.01% 655
2020
Q4
$16.8M Buy
107,663
+16,311
+18% +$2.55M 0.2% 102
2020
Q3
$10.5M Buy
91,352
+2,053
+2% +$235K 0.15% 138
2020
Q2
$10M Buy
89,299
+2,909
+3% +$327K 0.15% 132
2020
Q1
$7.76M Sell
86,390
-24
-0% -$2.16K 0.14% 131
2019
Q4
$9.35M Buy
86,414
+1,350
+2% +$146K 0.13% 128
2019
Q3
$8.33M Sell
85,064
-662
-0.8% -$64.8K 0.12% 146
2019
Q2
$11.2M Sell
85,726
-33
-0% -$4.32K 0.17% 108
2019
Q1
$11.6M Buy
85,759
+4,428
+5% +$599K 0.18% 102
2018
Q4
$7.92M Sell
81,331
-1,219
-1% -$119K 0.13% 135
2018
Q3
$11.5M Buy
82,550
+5,448
+7% +$757K 0.17% 110
2018
Q2
$9.57M Buy
77,102
+77,000
+75,490% +$9.56M 0.14% 122
2018
Q1
$11.4K Sell
102
-373
-79% -$41.6K ﹤0.01% 1681
2017
Q4
$56.8K Buy
475
+25
+6% +$2.99K ﹤0.01% 1303
2017
Q3
$63.1K Buy
450
+50
+13% +$7.02K ﹤0.01% 1263
2017
Q2
$48.7K Buy
+400
New +$48.7K ﹤0.01% 1382